E
Electromedical Technologies, Inc.
EMED
$0.0002
$0.000.00%
E
Sell
3/14/2023Downgrade
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Electromedical Technologies, Inc. (EMED) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Electromedical Technologies, Inc. (EMED) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the growth index. Operating cash flow declined 231.46% from -$97.9 to -$324.5, earnings per share declined from -$0.0047 to -$0.0067, and EBIT declined 19.1% from -$283.3 to -$337.4.
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the growth index. Operating cash flow declined 231.46% from -$97.9 to -$324.5, earnings per share declined from -$0.0047 to -$0.0067, and EBIT declined 19.1% from -$283.3 to -$337.4.
D
Sell
5/18/2022Upgraded
Electromedical Technologies, Inc. (EMED) was upgraded to D from D- on 5/18/2022 due to a significant increase in the growth index and total return index. Earnings per share increased from -$0.0661 to -$0.0124, and EBIT increased 51.32% from -$1.49M to -$725.6.
Electromedical Technologies, Inc. (EMED) was upgraded to D from D- on 5/18/2022 due to a significant increase in the growth index and total return index. Earnings per share increased from -$0.0661 to -$0.0124, and EBIT increased 51.32% from -$1.49M to -$725.6.
D
Sell
5/5/2022Upgraded
Electromedical Technologies, Inc. (EMED) was upgraded to D- from E+ on 05/05/2022.
Electromedical Technologies, Inc. (EMED) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index and total return index.
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index and total return index.
D
Sell
12/2/2021Downgrade
Electromedical Technologies, Inc. (EMED) was downgraded to D- from D on 12/2/2021 due to a decline in the total return index.
Electromedical Technologies, Inc. (EMED) was downgraded to D- from D on 12/2/2021 due to a decline in the total return index.
D
Sell
11/17/2021Upgraded
Electromedical Technologies, Inc. (EMED) was upgraded to D from D- on 11/17/2021 due to an increase in the growth index, total return index and volatility index. EBIT increased 57.96% from -$524.7 to -$220.6, operating cash flow increased 55.74% from -$401.3 to -$177.6, and total revenue increased 48.37% from $203 to $301.2.
Electromedical Technologies, Inc. (EMED) was upgraded to D from D- on 11/17/2021 due to an increase in the growth index, total return index and volatility index. EBIT increased 57.96% from -$524.7 to -$220.6, operating cash flow increased 55.74% from -$401.3 to -$177.6, and total revenue increased 48.37% from $203 to $301.2.
D
Sell
8/13/2021Upgraded
Electromedical Technologies, Inc. (EMED) was upgraded to D- from E+ on 8/13/2021 due to an increase in the growth index, volatility index and solvency index. Earnings per share increased from -$0.0897 to -$0.0216, EBIT increased 66.46% from -$1.56M to -$524.7, and debt to equity declined from -0.66 to -0.87.
Electromedical Technologies, Inc. (EMED) was upgraded to D- from E+ on 8/13/2021 due to an increase in the growth index, volatility index and solvency index. Earnings per share increased from -$0.0897 to -$0.0216, EBIT increased 66.46% from -$1.56M to -$524.7, and debt to equity declined from -0.66 to -0.87.
E
Sell
5/6/2021Downgrade
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D- on 5/6/2021 due to a decline in the volatility index.
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D- on 5/6/2021 due to a decline in the volatility index.
D
Sell
4/1/2021Upgraded
Electromedical Technologies, Inc. (EMED) was upgraded to D- from E+ on 4/1/2021 due to a noticeable increase in the solvency index. The quick ratio increased from 0.07 to 0.14.
Electromedical Technologies, Inc. (EMED) was upgraded to D- from E+ on 4/1/2021 due to a noticeable increase in the solvency index. The quick ratio increased from 0.07 to 0.14.
E
Sell
3/10/2021Downgrade
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D- on 3/10/2021 due to a noticeable decline in the total return index, growth index and volatility index. EBIT declined 156.13% from -$817.9 to -$2.09M, earnings per share declined from -$0.0409 to -$0.1, and operating cash flow declined 122.91% from -$246.6 to -$549.7.
Electromedical Technologies, Inc. (EMED) was downgraded to E+ from D- on 3/10/2021 due to a noticeable decline in the total return index, growth index and volatility index. EBIT declined 156.13% from -$817.9 to -$2.09M, earnings per share declined from -$0.0409 to -$0.1, and operating cash flow declined 122.91% from -$246.6 to -$549.7.
D
Sell
9/1/2020Upgraded
Electromedical Technologies, Inc. (ELCQ) was upgraded to D- from E+ on 9/1/2020 due to a major increase in the growth index and valuation index.
Electromedical Technologies, Inc. (ELCQ) was upgraded to D- from E+ on 9/1/2020 due to a major increase in the growth index and valuation index.
E
Sell
8/17/2020Downgrade
Electromedical Technologies, Inc. (ELCQ) was downgraded to E+ from D- on 8/17/2020 due to a noticeable decline in the solvency index, growth index and valuation index. Operating cash flow declined 35,328.57% from $700 to -$246.6, EBIT declined 86.82% from -$437.8 to -$817.9, and earnings per share declined from -$0.0248 to -$0.0409.
Electromedical Technologies, Inc. (ELCQ) was downgraded to E+ from D- on 8/17/2020 due to a noticeable decline in the solvency index, growth index and valuation index. Operating cash flow declined 35,328.57% from $700 to -$246.6, EBIT declined 86.82% from -$437.8 to -$817.9, and earnings per share declined from -$0.0248 to -$0.0409.
D
Sell
5/1/2020Upgraded
Electromedical Technologies, Inc. (ELCQ) was upgraded to D- from E on 5/1/2020 due to an increase in the valuation index and growth index.
Electromedical Technologies, Inc. (ELCQ) was upgraded to D- from E on 5/1/2020 due to an increase in the valuation index and growth index.
E
Sell
2/4/2020Upgraded
Electromedical Technologies, Inc. (ELCQ) was upgraded to E from E- on 2/4/2020 due to an increase in the valuation index.
Electromedical Technologies, Inc. (ELCQ) was upgraded to E from E- on 2/4/2020 due to an increase in the valuation index.
E
Sell
12/10/2019Downgrade
Electromedical Technologies, Inc. (ELCQ) was downgraded to E- from E on 12/10/2019 due to a decline in the volatility index and total return index.
Electromedical Technologies, Inc. (ELCQ) was downgraded to E- from E on 12/10/2019 due to a decline in the volatility index and total return index.
E
Sell
11/25/2019Upgraded
Electromedical Technologies, Inc. (ELCQ) was upgraded to E from E- on 11/25/2019 due to a large increase in the total return index, growth index and efficiency index.
Electromedical Technologies, Inc. (ELCQ) was upgraded to E from E- on 11/25/2019 due to a large increase in the total return index, growth index and efficiency index.
E
Sell
11/6/2019None
Electromedical Technologies, Inc. (EMED) was downgraded to E- from U on 11/06/2019.
Electromedical Technologies, Inc. (EMED) was downgraded to E- from U on 11/06/2019.
OTC PK
03/12/2025 12:01PM Eastern
Quotes delayed
